EP1778266A4 - COMPOSITIONS AND METHODS FOR PREVENTING AND REGULATING INSULIN-INDUCED HYPOGLYCEMIA - Google Patents

COMPOSITIONS AND METHODS FOR PREVENTING AND REGULATING INSULIN-INDUCED HYPOGLYCEMIA

Info

Publication number
EP1778266A4
EP1778266A4 EP05787795A EP05787795A EP1778266A4 EP 1778266 A4 EP1778266 A4 EP 1778266A4 EP 05787795 A EP05787795 A EP 05787795A EP 05787795 A EP05787795 A EP 05787795A EP 1778266 A4 EP1778266 A4 EP 1778266A4
Authority
EP
European Patent Office
Prior art keywords
insulin
prevention
compositions
methods
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05787795A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1778266A2 (en
Inventor
Daniel T Green
Robert R Henry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DiObex Inc
Original Assignee
DiObex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DiObex Inc filed Critical DiObex Inc
Publication of EP1778266A2 publication Critical patent/EP1778266A2/en
Publication of EP1778266A4 publication Critical patent/EP1778266A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP05787795A 2004-06-29 2005-06-27 COMPOSITIONS AND METHODS FOR PREVENTING AND REGULATING INSULIN-INDUCED HYPOGLYCEMIA Withdrawn EP1778266A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58444904P 2004-06-29 2004-06-29
PCT/US2005/022812 WO2006004696A2 (en) 2004-06-29 2005-06-27 Compositions and methods for the prevention and control of insulin-induced hypoglycemia

Publications (2)

Publication Number Publication Date
EP1778266A2 EP1778266A2 (en) 2007-05-02
EP1778266A4 true EP1778266A4 (en) 2009-09-09

Family

ID=35783298

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05787795A Withdrawn EP1778266A4 (en) 2004-06-29 2005-06-27 COMPOSITIONS AND METHODS FOR PREVENTING AND REGULATING INSULIN-INDUCED HYPOGLYCEMIA

Country Status (11)

Country Link
EP (1) EP1778266A4 (enExample)
JP (1) JP2008505087A (enExample)
KR (1) KR20070029276A (enExample)
CN (1) CN101001638A (enExample)
AU (1) AU2005260025A1 (enExample)
CA (1) CA2571030A1 (enExample)
IL (1) IL180361A0 (enExample)
MX (1) MXPA06014970A (enExample)
NO (1) NO20070174L (enExample)
WO (1) WO2006004696A2 (enExample)
ZA (1) ZA200700708B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2816114C (en) 2010-11-03 2019-02-12 Jan Jezek Novel composition comprising glucagon
CN107949374B (zh) * 2015-09-04 2022-04-08 莱迪杜德制药公司 稳定的胰高血糖素溶液
GB201611077D0 (en) 2016-06-24 2016-08-10 Arecor Ltd Novel composition
CN110446496A (zh) * 2017-02-03 2019-11-12 范德比尔特大学 用于治疗糖尿病的系统、组合物和方法
BR112020000447A2 (pt) * 2017-07-14 2020-07-21 Xeris Pharmaceuticals, Inc. métodos de tratamento de hiperinsulinismo congênito
WO2019108640A1 (en) * 2017-11-28 2019-06-06 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods and kits for evaluating metabolism
WO2021263197A1 (en) * 2020-06-26 2021-12-30 Xeris Pharmaceuticals, Inc. Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
GB202109087D0 (en) * 2021-06-24 2021-08-11 Norwegian Univ Sci & Tech Ntnu Therapeutic methods and devices

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004060387A1 (en) * 2002-12-27 2004-07-22 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897551A (en) * 1971-04-05 1975-07-29 Lilly Co Eli Iodoglucagons and process for prolonging the biological activity of glucagon
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
WO2004046106A1 (en) * 2002-11-18 2004-06-03 Pfizer Products Inc. Dipeptidyl peptidase iv inhibiting fluorinated cyclic amides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004060387A1 (en) * 2002-12-27 2004-07-22 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
CRYER PHILIP E ET AL: "Hypoglycemia in diabetes.", DIABETES CARE JUN 2003, vol. 26, no. 6, June 2003 (2003-06-01), pages 1902 - 1912, XP002538099, ISSN: 0149-5992 *
DE GALAN B E ET AL: "Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes", NETHERLANDS JOURNAL OF MEDICINE, vol. 64, no. 8, September 2006 (2006-09-01), pages 269 - 279, XP002538100, ISSN: 0300-2977 *
EDELMAN S V ET AL: "Subcutaneous infusion of very low dose-glucagon averts insulin induced hypoglycaemia in patients with type 1 diabetes mellitus", DIABETOLOGIA, vol. 49, no. Suppl. 1, September 2006 (2006-09-01), & 42ND ANNUAL MEETING OF THE EUROPEAN-ASSOCIATION-FOR-THE-STUDY-OF-DIA BETES (EASD); COPENHAGEN, DENMARK; SEPTEMBER 14 -17, 2006, pages 506, XP009120428, ISSN: 0012-186X *
EDELMAN STEVEN ET AL: "Nocturnal administration of very low dose glucagon in patients with type 1 diabetes reduces episodes of nocturnal hypoglycemia", DIABETES, vol. 56, no. Suppl. 1, June 2007 (2007-06-01), & 67TH ANNUAL MEETING OF THE AMERICAN-DIABETES-ASSOCIATION; CHICAGO, IL, USA; JUNE 22 -26, 2007, pages A8 - A9, XP009120378, ISSN: 0012-1797 *
FANELLI C G ET AL: "Glucagon: the effects of its excess and deficiency on insulin action.", NUTRITION, METABOLISM, AND CARDIOVASCULAR DISEASES : NMCD MAR 2006, vol. 16 Suppl 1, March 2006 (2006-03-01), pages S28 - S34, XP002538101, ISSN: 0939-4753 *
HAYMOND M W ET AL: "Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes.", DIABETES CARE APR 2001, vol. 24, no. 4, April 2001 (2001-04-01), pages 643 - 645, XP002538098, ISSN: 0149-5992 *
ISLEY WILLIAM ET AL: "Very low dose glucagon averts insulin induced Hypoglycemia in patients with type 1 diabetes", DIABETES, vol. 55, no. Suppl. 1, June 2006 (2006-06-01), & 66TH ANNUAL MEETING OF THE AMERICAN-DIABETES-ASSOCIATION; WASHINGTON, DC, USA; JUNE 09 -13, 2006, pages A117, XP009120392, ISSN: 0012-1797 *

Also Published As

Publication number Publication date
IL180361A0 (en) 2007-06-03
KR20070029276A (ko) 2007-03-13
CN101001638A (zh) 2007-07-18
WO2006004696A2 (en) 2006-01-12
AU2005260025A1 (en) 2006-01-12
MXPA06014970A (es) 2007-03-07
EP1778266A2 (en) 2007-05-02
JP2008505087A (ja) 2008-02-21
NO20070174L (no) 2007-03-13
CA2571030A1 (en) 2006-01-12
ZA200700708B (en) 2009-03-25
WO2006004696A3 (en) 2006-10-26

Similar Documents

Publication Publication Date Title
EP1578437A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING AND REDUCING INSULIN-INDUCED HYPOGLYCEMIA
IL181896A0 (en) Methods and compositions for the treatment of hyperlipidemia
AU2005339139A8 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
IL182863A0 (en) Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof
PT3006040T (pt) Métodos e composições para o tratamento de neuropatias
PL1771201T3 (pl) Kompozycje i sposoby leczenia lub profilaktyki choroby związanej ze szczawianem
IL187617A0 (en) Lkktet and/or lkktnt peptide compositions and methods
IL183709A0 (en) Compositions and methods for treating conditions of the nail unit
IL183986A0 (en) Pharmaceutical compounds and compositions
ZA200800448B (en) Methods and compositions for the prevention and treatment of inflammatory disease
IL187565A0 (en) Compositions and methods for the treatment or prevention of chemoresistant neoplasia
IL186325A0 (en) Tizanidine compositions and methods of treatment using the compositions
ZA200703087B (en) Methods and compositions for the treatment of hyperlipidemia
PL1762219T3 (pl) Fotoochronne i/lub fotoimmunoochronne kompozycje do skóry i ich zastosowania
IL180361A0 (en) Compositions and methods for the prevention and control of insulin-induced hypoglycemia
IL186337A0 (en) Stannsoporfin compositions and administration
EP1909809A4 (en) METHOD AND COMPOSITION FOR TREATING DIABETES AND ITS COMPLICATIONS
EP1812797A4 (en) COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HYPERPROLIFERATIVE DISEASES
EP1776956A4 (en) PREVENTIVE AND / OR THERAPEUTIC AGENT FOR CALCIPENIA
GB0424051D0 (en) Compounds and compositions
PT2474528E (pt) Compostos antineoplásicos e composições farmacêuticas dos mesmos
EP1865777A4 (en) STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION
IL180526A (en) Composition for the prevention and treatment of allergic inflammatory disease
HU0400960D0 (en) Composition for controlling louses and its larvae and method for controlling louses
GB0618309D0 (en) Compositions and methods for the treatment of disease

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070117

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090806

17Q First examination report despatched

Effective date: 20120522

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121002